Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tareq M I Salah, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Dhaver S, Al-Badri M, Salah T, Kilroy C, Shahar J, Johnson C, Votta J, Mitchell C, Beaton J, Khater A, Kibaa K, McCarragher R, Davis C, Hamdy O. Hybrid model of intensive lifestyle intervention is potentially effective in patients with diabetes & obesity for post-COVID era. Front Endocrinol (Lausanne). 2022; 13:1050527. PMID: 36733796; PMCID: PMC9887117.
    Citations:    Fields:    Translation:Humans
  2. SHAHEEN TOMAH; TAREQ SALAH; MARWA AL-BADRI; SHILTON E. DHAVER; MICHAEL P. CURRY; ZHENGHUI JIANG; MICHELLE LAI; OMNIA A. ELENANI; KARIM KIBAA; HANNAH GARDNER; RYAN MCCARRAGHER; AARYA A. KAUSHIK; NOLAN A. ZIEMNIAK; OSAMA HAMDY. 1105-P Moderate-to-Advanced Liver Fibrosis Is Common in Patients with Type 1 Diabetes (T1D) and Nonalcoholic Fatty Liver Disease (NAFLD). Moderate-to-Advanced Liver Fibrosis Is Common in Patients with Type 1 Diabetes (T1D) and Nonalcoholic Fatty Liver Disease (NAFLD). 2022; 71(1). View Publication.
  3. Ahmed S, M Kamal S, Salah T, Fawzy Sedik M, Youssief AA. Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin. J Bone Oncol. 2021 Dec; 31:100395. PMID: 34712554; PMCID: PMC8529095.
    Citations: 1     
  4. Al-Saleh K, Salah T, Arafah M, Husain S, Al-Rikabi A, Abd El-Aziz N. Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia. PLoS One. 2021; 16(3):e0247802. PMID: 33667252.
    Citations: 2     Fields:    Translation:Humans
  5. Al-Saleh K, Aldiab A, Salah T, Arafah M, Husain S, Al-Rikabi A, El-Aziz NA. Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer. Clin Breast Cancer. 2021 08; 21(4):e362-e367. PMID: 33419688.
    Citations:    Fields:    Translation:Humans
  6. Farhan MA, Moharram AM, Salah T, Shaaban OM. Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Med Mycol. 2019 Aug 01; 57(6):681-687. PMID: 30544194.
    Citations: 11     Fields:    Translation:HumansAnimals
  7. SHAHEEN TOMAH; MHD WAEL TASABEHJI; FAYEZ GHAZI; TAREQ SALAH; HONGXIA ZHANG; SAHAR ASHRAFZADEH; OSAMA HAMDY. 2066-P: Improvement of Hepatic Steatosis Index in Patients with Type 1 Diabetes and Obesity after Intensive Lifestyle Intervention: A One-Year Matched-Cohort Observational Study. Improvement of Hepatic Steatosis Index in Patients with Type 1 Diabetes and Obesity after Intensive Lifestyle Intervention: A One-Year Matched-Cohort Observational Study. 2019; 68(1).
  8. Al-Saleh K, Abd El-Aziz N, Ali A, Abo Zeed W, Salah T, Elsamany S, Rasmy A, El Farargy O, Husain S, Al-Rikabi A, Alsaeed E, Aldiab A, Abd El-Warith A. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC). Gulf J Oncolog. 2019 May; 1(30):33-42. PMID: 31242980.
    Citations: 1     Fields:    Translation:Humans
  9. Makboul R, Hassan HM, Refaiy A, Abdelkawi IF, Shahat AA, Hameed DA, Morsy A, Salah T, Ahmed Mohammed RA. A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma. Clin Genitourin Cancer. 2019 06; 17(3):e712-e719. PMID: 31085058.
    Citations: 4     Fields:    Translation:Humans
  10. Buwenge M, Marinelli A, Deodato F, Macchia G, Wondemagegnhu T, Salah T, Cammelli S, Uddin AFMK, Sumon MA, Donati CM, Cilla S, Morganti AG. Definition of fields margins for palliative radiotherapy of pancreatic carcinoma. Mol Clin Oncol. 2018 Jun; 8(6):715-718. PMID: 29844901; PMCID: PMC5958799.
    Citations: 2     
  11. Zedan A, Salah T. Total mesorectal excision for the treatment of rectal cancer. Electron Physician. 2015 Dec; 7(8):1666-72. PMID: 26816592; PMCID: PMC4725422.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Salah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (50)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.